|
|
Tim Boreham interviews Anatara CEO Steven Lydeamore for Dr Boreham's Crucible
Dear Investors,
Anatara Lifesciences CEO Steve Lydeamore recently spoke with experienced business writer, Tim Boreham, for his Dr Boreham's Crucible column which was published in Biotech Daily on Friday night and then reproduced in Stockhead across the weekend.
Steve spoke with Tim about the Company's evolving story into the human health space, the growing concern around the use of antibiotics in agriculture and the opportunity a product like Detach presents. The discussion also covered how the Company is setting itself up to play in the expansive market for over-the-counter gastrointestinal and digestive products with its Gastrointestinal ReProgramming (GaRP) dietary supplement "a three pronged approach to bug busting".
Dr Boreham's Crucible: Anatara Lifesciences can be read here.
For further information on Anatara Lifesciences, a copy of our latest Corporate Fact Sheet can be found here.
|
|
|
|
|
|
|